<DOC>
	<DOCNO>NCT02292719</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy ombitasvir/ABT-450/r sofosbuvir without ribavirin adult Genotype 2 Chronic Hepatitis C Virus ( HCV ) infection Genotype 3 HCV infection With Without Cirrhosis .</brief_summary>
	<brief_title>A Study Evaluate Safety Efficacy Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With Without Ribavirin Adults With Chronic Hepatitis C Virus Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>1 . Chronic HCV infection prior study enrollment . 2 . Screening laboratory result central clinical laboratory indicate HCV genotype 2 3 infection ( mixed genotype ) . 3 . Absence OR presence cirrhosis . 4 . If cirrhotic , need compensate cirrhosis absence hepatocellular carcinoma ( HCC ) 1 . Positive screen hepatitis B surface antigen antihuman immunodeficiency virus antibody 2 . Recent ( within 6 month prior study drug administration ) history drug alcohol abuse . 3 . Current enrollment another clinical study , previous enrolment study , previous use investigational commercially available antiHCV therapy ( interferon , pegIFN , RBV , SOF ) include previous exposure telaprevir , boceprevir , ABT450 , ombitasvir ( ABT267 ) . 4 . Subjects without cirrhosis : Any current past clinical evidence cirrhosis . 5 . Abnormal lab test . 6 . Females pregnant plan become pregnant breastfeeding , male whose partner pregnant plan become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Hepatitis C Virus</keyword>
	<keyword>Genotype 2</keyword>
	<keyword>Chronic Hepatitis C</keyword>
	<keyword>Genotype 3</keyword>
	<keyword>Non-cirrhotic</keyword>
	<keyword>Cirrhotic</keyword>
</DOC>